Correlation Between Verrica Pharmaceuticals and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Kura Oncology, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Kura Oncology.
Diversification Opportunities for Verrica Pharmaceuticals and Kura Oncology
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Kura is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Kura Oncology go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Kura Oncology
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 1.37 times more return on investment than Kura Oncology. However, Verrica Pharmaceuticals is 1.37 times more volatile than Kura Oncology. It trades about 0.05 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.12 per unit of risk. If you would invest 70.00 in Verrica Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 2.00 from holding Verrica Pharmaceuticals or generate 2.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Kura Oncology
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Kura Oncology |
Verrica Pharmaceuticals and Kura Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Kura Oncology
The main advantage of trading using opposite Verrica Pharmaceuticals and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets |